The telehealth weight-loss market shifted hard in early 2026. A Novo Nordisk settlement in March forced dozens of platforms off compounded semaglutide, FDA warning letters went to more than 30 compounding operations, and Lilly quietly launched oral orforglipron through its own direct channel at roughly $149 a month. What you could buy six months ago often no longer exists at the same price or through the same pharmacy. This list reflects where things actually stand.
1. HealthRX
Verdict: Best overall cash-pay option for most people.
The single fact that earns HealthRX the top slot: compounded semaglutide starts at $99 a month and tirzepatide at $149, with free overnight shipping to all 50 states and a named dispensing pharmacy, Manifest Pharmacy in Greer, South Carolina, operating under 503A/USP-797 standards with lot-level tracking. That pharmacy holds LegitScript certification (cert 50087439). A board-certified physician reviews your intake form in roughly 24 hours. Pricing is posted upfront. No hidden fees. The clinical efficacy numbers HealthRX references come from published trials: SURMOUNT-1 showed about 21% body weight loss at 72 weeks with tirzepatide, and STEP 1 showed roughly 15% at 68 weeks with semaglutide. These are compounded medications, not FDA-approved drugs, and no telehealth compound is equivalent to a branded product. Still, for cash-pay access with transparent sourcing at this price point, nothing else on this list matches the combination.
2. FormBlends
Verdict: Best pick if you want published lab testing or a broader peptide catalog.
FormBlends runs a compounded GLP-1 program through an FDA-registered 503A pharmacy and publishes per-product purity testing with actual numbers, including HPLC purity percentages, mass spec identity confirmation, and endotoxin/sterility results. Posting that kind of batch-level documentation is rare across GLP-1 telehealth. Compounded semaglutide is priced at approximately $299 per vial and tirzepatide at approximately $349 per vial. That is meaningfully higher than HealthRX. Ships to 47 states. It also carries a wide peptide catalog covering recovery, longevity, and cognitive compounds under the same clinician model, which is genuinely unusual in this category. If price-per-month is your first filter, HealthRX wins. If published batch-level purity data or access to a broader compounded peptide menu matters more to you, FormBlends is the stronger choice.
3. Mochi Health
Verdict: Strong monitoring, low compounded price.
Compounded semaglutide at roughly $99 a month and tirzepatide around $199. Mochi uses board-certified obesity-medicine clinicians, which is a real credential distinction. More hands-on monitoring than most platforms at this price.
4. Hims & Hers
Verdict: Big brand, now branded meds only.
After the March 2026 Novo settlement, Hims & Hers exited compounded GLP-1s. Injectable Wegovy runs around $299 a month through them, oral options around $249, and Zepbound around $399. With insurance plus a savings card, some patients land at $0 to $25. Good fit if you want branded product and insurance coordination. Cash-pay cost is high compared to compounders.
*A quick honest note here: compounded GLP-1s from any provider are not FDA-approved, and the long-term safety data on compounded formulations is thinner than for branded drugs. Worth factoring in before you choose.*
5. Ro Body
Verdict: Solid insurance support, reasonable entry price.
First month runs about $39, then $74 to $149 a month for the membership, with medications billed separately. Ro has an actual prior-authorization team to fight insurance denials, which saves real time for patients going the branded-med route.
6. Henry Meds
Verdict: Fast shipping, light touch.
Cash-pay compounded medications with shipping in 24 to 72 hours. First-month pricing around $179 to $249. Monitoring is lighter than Mochi or Form Health. Good for people who want quick access without a heavy coaching layer.
7. PlushCare
Verdict: Cheapest membership, same-day visits.
Membership is $19.99 a month. Same-day appointments are genuinely available. Focuses on branded medications with insurance billing. Not a cash-pay compounding play.
8. Found
Verdict: Platform plus coaching at a flat rate.
About $99 a month covers the platform and coaching layer. Medications are billed on top. Broader behavioral health integration than most purely prescription-focused platforms.
9. Eden
Verdict: Simple cash-pay compounding, mid-range price.
Compounded semaglutide around $149 a month. Straightforward process, no frills. Ships widely but lacks the pharmacy transparency that HealthRX or FormBlends publish.
10. WeightWatchers Clinic
Verdict: Familiar brand, separate program fee.
Program fee around $74 a month, medications separate. The WW behavioral framework is layered on top of the clinical prescription piece. Redundant for someone who just wants medication access, but potentially useful for people who already use WW.
11. Calibrate
Verdict: Long commitment, full program.
Calibrate runs roughly 12 months and separates program fees from medication costs. Heavy coaching and lab work included. Higher total cost. Not the right pick for someone who wants a simple monthly prescription.
12. Form Health
Verdict: Premium tier, full clinical team.
Around $299 a month plus labs plus medications. You get an MD and a registered dietitian working together. The most clinically intensive option on this list, and the most expensive. Justified for complex cases, overkill for straightforward ones.
How to Choose
Price alone should not decide this. Know whether your pharmacy is named and has verifiable credentials. Understand whether you are getting a compounded or branded product. Check which states the provider ships to before you start an intake form. If your insurer covers branded GLP-1s, Ro or PlushCare may net you a lower real cost than any compounder.
Common Questions
Is compounded semaglutide from HealthRX or Mochi the same drug as Wegovy?
No. Compounded semaglutide is a copy produced by a 503A pharmacy, not the FDA-approved branded product. The active molecule is the same, but compounded versions skip the FDA approval process entirely. Branded drugs like Wegovy carry more long-term safety data and consistent manufacturing oversight than any compounded alternative currently on the market.
After the March 2026 Novo Nordisk settlement, which providers on this list can still offer compounded semaglutide?
Providers using 503A pharmacies that meet specific clinical criteria may still prescribe compounded semaglutide legally, though the rules tightened significantly. HealthRX, FormBlends, Mochi Health, Henry Meds, and Eden were still offering compounded versions as of this writing. Hims & Hers exited compounded GLP-1s entirely following the settlement.
Why does FormBlends charge nearly three times what HealthRX charges for what appears to be the same compound?
The price difference largely reflects FormBlends publishing batch-level purity data, including HPLC percentages and mass spec confirmation, which costs money to produce and verify. You are also paying for access to a broader peptide catalog under the same clinical model. If you only want semaglutide at the lowest verified price, that premium is hard to justify. If documented purity matters to you, it is a real difference.
Does Ro Body’s prior-authorization team actually improve approval odds, or is that just marketing?
Prior-authorization support is a real operational function, not a buzzword. Insurance denials for GLP-1s are common, and having staff who know the appeal process and correct diagnosis coding does meaningfully improve approval rates compared to patients working through it alone. It is most valuable if you have insurance that covers Wegovy or Zepbound but has denied the claim once already.
What should I check about a compounding pharmacy before I start a GLP-1 program through any of these platforms?
Three things matter most. First, confirm the pharmacy is named, not just described as “an FDA-registered facility.” Second, look up the pharmacy on LegitScript or the state board of pharmacy database. Third, ask whether lot-level testing results are available for the specific batch you will receive. HealthRX names Manifest Pharmacy with a LegitScript cert number. FormBlends publishes actual purity data. Most others on this list do not go that far.
Sources
- FDA warning letters to telehealth/compounding firms, early 2026 (FDA.gov)
- Novo Nordisk settlement announcement, March 2026 (Reuters, Fierce Pharma)
- SURMOUNT-1 trial results, tirzepatide (NEJM, 2022)
- STEP 1 trial results, semaglutide (NEJM, 2021)
- LillyDirect orforglipron pricing, April 2026 (Eli Lilly press release)
- LegitScript pharmacy certification database (LegitScript.com)
